HK1024929A1 - Polypeptides encoded by a human lipase-like gene, compositions and methods. - Google Patents

Polypeptides encoded by a human lipase-like gene, compositions and methods.

Info

Publication number
HK1024929A1
HK1024929A1 HK00102627A HK00102627A HK1024929A1 HK 1024929 A1 HK1024929 A1 HK 1024929A1 HK 00102627 A HK00102627 A HK 00102627A HK 00102627 A HK00102627 A HK 00102627A HK 1024929 A1 HK1024929 A1 HK 1024929A1
Authority
HK
Hong Kong
Prior art keywords
gene
compositions
methods
polypeptides encoded
human lipase
Prior art date
Application number
HK00102627A
Other languages
English (en)
Inventor
Michael C Jaye
Kim-Anh Thi Doan
John A Krawec
Kevin J Lynch
Dilip V Amin
Victoria J South
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of HK1024929A1 publication Critical patent/HK1024929A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK00102627A 1996-12-06 2000-05-02 Polypeptides encoded by a human lipase-like gene, compositions and methods. HK1024929A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3225496P 1996-12-06 1996-12-06
US3278396P 1996-12-06 1996-12-06
PCT/US1997/022331 WO1998024888A2 (en) 1996-12-06 1997-12-05 Polypeptides encoded by a human lipase-like gene, compositions and methods

Publications (1)

Publication Number Publication Date
HK1024929A1 true HK1024929A1 (en) 2000-10-27

Family

ID=26708180

Family Applications (2)

Application Number Title Priority Date Filing Date
HK00102627A HK1024929A1 (en) 1996-12-06 2000-05-02 Polypeptides encoded by a human lipase-like gene, compositions and methods.
HK05100955.8A HK1068636A1 (en) 1996-12-06 2005-02-04 Polypeptides encoded by a human lipase-like gene, compositions and methods

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK05100955.8A HK1068636A1 (en) 1996-12-06 2005-02-04 Polypeptides encoded by a human lipase-like gene, compositions and methods

Country Status (22)

Country Link
US (4) US6395530B1 (de)
EP (1) EP0948609B1 (de)
JP (2) JP4615634B2 (de)
KR (1) KR100516561B1 (de)
CN (2) CN1167793C (de)
AP (1) AP1313A (de)
AT (1) ATE291080T1 (de)
AU (1) AU750891B2 (de)
BG (1) BG64798B1 (de)
BR (1) BR9713847A (de)
CA (1) CA2273823C (de)
CZ (1) CZ299055B6 (de)
DE (2) DE69732789T2 (de)
EA (1) EA003293B1 (de)
ES (1) ES2239367T3 (de)
HK (2) HK1024929A1 (de)
IL (2) IL129986A0 (de)
NO (1) NO326140B1 (de)
OA (1) OA11057A (de)
PL (1) PL191624B1 (de)
SK (1) SK287687B6 (de)
WO (1) WO1998024888A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1313A (en) 1996-12-06 2004-10-04 Aventis Pharma Inc Polypeptides encoded by a human lipase-like gene, composition and method.
US7008776B1 (en) * 1996-12-06 2006-03-07 Aventis Pharmaceuticals Inc. Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
US7692067B2 (en) * 2002-09-18 2010-04-06 Mendel Biotechnology, Inc. Yield and stress tolerance in transgenic plants
NZ514350A (en) * 1999-03-26 2004-12-24 Aventis Pharma Inc Compositions and methods for effecting the levels of cholesterol
GB9920334D0 (en) * 1999-08-28 1999-11-03 Glaxo Group Ltd Method
US6337187B1 (en) * 1999-11-05 2002-01-08 Millennium Pharmaceuticals, Inc. 18891, a novel human lipase
WO2001032885A2 (en) * 1999-11-05 2001-05-10 Millennium Pharmaceuticals, Inc. Human lipase
WO2002024898A2 (en) * 2000-09-25 2002-03-28 Millennium Pharmaceuticals, Inc. 47647, a human lipase and uses therefor
US7507808B2 (en) * 2002-12-12 2009-03-24 Isis Pharmaceuticals, Inc. Modulation of endothelial lipase expression
CN102250854B (zh) * 2011-07-01 2013-03-27 浙江商达环保有限公司 用于处理油脂污染物的脂肪酶、编码基因及其应用
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
MA41035A (fr) * 2014-08-19 2017-08-15 Shire Human Genetic Therapies Lipoprotéine lipase pour le traitement d'affections liées à une hypertriglycéridémie, y compris la pancréatite aiguë
TWI734410B (zh) * 2014-09-11 2021-07-21 日商塩野義製藥股份有限公司 阻礙血管內皮脂酶之酵素活性的人類化單株抗體

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691181A (en) * 1984-08-21 1997-11-25 Celltech Limited DNA encoding lipase from human gastric mucosal tissue
FR2573436B1 (fr) 1984-11-20 1989-02-17 Pasteur Institut Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
JP2764264B2 (ja) 1987-10-01 1998-06-11 株式会社ミドリ十字 線溶活性増強剤
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5364777A (en) * 1992-04-03 1994-11-15 American Air Liquide Method of improving lipase activity using noble gases
HRP930935A2 (en) * 1992-06-11 1994-12-31 Astra Ab New dna sequences
DK88892D0 (da) * 1992-07-06 1992-07-06 Novo Nordisk As Forbindelse
CA2137558A1 (en) 1992-07-17 1994-02-03 Wayne A. Marasco Method of intracellular binding of target molecules
US5998189A (en) * 1992-12-16 1999-12-07 Warner-Lambert Company Polypeptide derivatives of dog gastric lipase and pharmaceutical compositions containing same
EP0687300B1 (de) * 1993-03-05 2001-09-12 Universite Catholique De Louvain Lo-cd2a antikörper und dessen verwendung zur inhibition von t-zell-aktivierung und -wachstum
FR2704556B1 (fr) 1993-04-30 1995-07-13 Rhone Poulenc Rorer Sa Virus recombinants et leur utilisation en thérapie génique.
FR2705686B1 (fr) 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
FR2706486B1 (fr) 1993-06-16 1995-09-01 Rhone Poulenc Rorer Sa Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques.
RU2219241C2 (ru) 1993-07-13 2003-12-20 Рон-Пуленк Роре С.А. Дефектный рекомбинантный аденовирусный вектор (варианты)
FR2714830B1 (fr) 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
FR2715847B1 (fr) 1994-02-08 1996-04-12 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
AU1806795A (en) * 1994-02-22 1995-09-04 Novo Nordisk A/S A method of preparing a variant of a lipolytic enzyme
US5807746A (en) 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
FR2730637B1 (fr) 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
AU6221496A (en) 1995-05-31 1996-12-18 Simon Lodewijk Scharpe Composition to improve digestibility and utilisation of nutr ients
AP1313A (en) 1996-12-06 2004-10-04 Aventis Pharma Inc Polypeptides encoded by a human lipase-like gene, composition and method.
US7008776B1 (en) * 1996-12-06 2006-03-07 Aventis Pharmaceuticals Inc. Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
WO1999032611A1 (en) 1997-12-19 1999-07-01 Progenitor, Inc. A lipase expressed in endothelial cells and methods for its use
US6337187B1 (en) * 1999-11-05 2002-01-08 Millennium Pharmaceuticals, Inc. 18891, a novel human lipase
US6558936B1 (en) * 1999-10-01 2003-05-06 Millennium Pharmaceuticals, Inc. Human lipase proteins, nucleic acids encoding them, and uses of both of these

Also Published As

Publication number Publication date
AU5690598A (en) 1998-06-29
NO992735D0 (no) 1999-06-04
SK287687B6 (sk) 2011-06-06
EA003293B1 (ru) 2003-04-24
ATE291080T1 (de) 2005-04-15
HK1068636A1 (en) 2005-04-29
JP2010284171A (ja) 2010-12-24
EP0948609B1 (de) 2005-03-16
KR100516561B1 (ko) 2005-09-22
WO1998024888A3 (en) 1998-08-13
US20030108538A1 (en) 2003-06-12
CZ299055B6 (cs) 2008-04-09
CA2273823A1 (en) 1998-06-11
CN1240000A (zh) 1999-12-29
KR20000069336A (ko) 2000-11-25
IL129986A0 (en) 2000-02-29
AP1313A (en) 2004-10-04
US20070101451A1 (en) 2007-05-03
SK75399A3 (en) 2001-02-12
CN1167793C (zh) 2004-09-22
US20120114660A1 (en) 2012-05-10
DE69732789T2 (de) 2005-08-11
BG64798B1 (bg) 2006-04-28
CN100497610C (zh) 2009-06-10
OA11057A (en) 2002-03-08
US7579447B2 (en) 2009-08-25
AP9901548A0 (en) 1999-06-30
EA199900522A1 (ru) 2000-02-28
ES2239367T3 (es) 2005-09-16
US8343494B2 (en) 2013-01-01
NO326140B1 (no) 2008-10-06
PL191624B1 (pl) 2006-06-30
IL129986A (en) 2006-07-05
US6395530B1 (en) 2002-05-28
WO1998024888A2 (en) 1998-06-11
DE948609T1 (de) 2000-03-09
EP0948609A2 (de) 1999-10-13
US7056720B2 (en) 2006-06-06
BR9713847A (pt) 2000-02-29
DE69732789D1 (de) 2005-04-21
JP5416053B2 (ja) 2014-02-12
CA2273823C (en) 2007-06-05
NO992735L (no) 1999-08-05
CN1539849A (zh) 2004-10-27
JP2001505769A (ja) 2001-05-08
AU750891B2 (en) 2002-08-01
JP4615634B2 (ja) 2011-01-19
BG103472A (en) 2001-01-31
CZ9902003A3 (cs) 2000-10-11

Similar Documents

Publication Publication Date Title
HK1068636A1 (en) Polypeptides encoded by a human lipase-like gene, compositions and methods
AU5850798A (en) Polynucleotides encoding proexendin, and methods and uses thereof
ZA972727B (en) A novel composition, its preparation and use.
ZA97177B (en) Toothbrush.
ZA979585B (en) Pesticidal methods, compositions and devices.
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
ZA971272B (en) Gene expression.
GB9608488D0 (en) Compositions, processes and uses
GB9608485D0 (en) Compositions, processes and uses
AU2068599A (en) Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation
AU1509501A (en) A novel polypeptide, a human deafness-related gene 14 and the polynucleotide encoding the polypeptide
AU6553898A (en) Human secreted protein, ba3.1, and polynucleotides encoding same
HK1057643A1 (en) Time switch.
WO1999035263A3 (en) Il-17rh dna and polypeptides
GB9608489D0 (en) Compositions, processes and uses
GB9608487D0 (en) Compositions, processes and uses
AU8953401A (en) A novel polypeptide, a human protein 16.83 ftsh and the polynucleotide encoding the polypeptide
AU9362801A (en) A novel polypeptide, a human protein 10 containing a group and the polynucleotide encoding the polypeptide
AU4632401A (en) A novel polypeptide, cytochrome human constitution protein 10 and the polynucleotide encoding the polypeptide
ZA974385B (en) Rotary biological contactor.
AU8948801A (en) A novel polypeptide, a human transformer-2-beta protein 29.15 and the polynucleotide encoding the polypeptide
AU5606201A (en) A novel polypeptide, human immunophiline 14 and the polynucleotide encoding the polypeptide
AU9539601A (en) A novel polypeptide, a human fascicular and elongation protein 12.87 and the polynucleotide encoding the polypeptide
AU8949001A (en) A novel polypeptide, a human ccr4 relative protein 9.5 and the polynucleotide encoding the polypeptide
AU8950901A (en) A novel polypeptide, a human sigma receptor 10.67 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151205